VIRO ViroGates A/S

1.042USD7.100 DKK · CPH+2.16%Mkt Cap: 9.67M USDP/E: —

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector. It offers suPARnostic TurbiLatex, a CE-IVD approved particle-enhanced turbidime…

Key Statistics

Company
Market Cap9.67M USD
Enterprise Value8.02M USD
Revenue (TTM)1.29M USD
Gross Profit971.57K USD
Net Income (TTM)-1.53M USD
Revenue/Share0.17 USD
Last Price1.042 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees7
CountryDK
SectorHealthcare
IndustryMedical Devices
ISINDK0061030574
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA—
EV/Revenue6.21
P/S7.49
P/B3.40
EPS (TTM)-0.14 USD
EPS (Forward)—
52W Range
0.88789% of range2.553
52W High2.553 USD
52W Low0.8878 USD
Profitability
Gross Margin74.36%
Oper. Margin-104.67%
EBITDA Margin0.00%
Profit Margin-116.77%
ROE-53.58%
ROA-33.99%
ROIC—
ROCE-46.07%
Growth
Revenue Growth-33.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-605.31K USD
CapEx (TTM)—
FCF Margin-113.64%
FCF Yield-15.17%
Net Debt-1.65M USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity0.24
Current Ratio6.31
Quick Ratio5.78
Book Value/Sh0.31 USD
Cash/Share0.24 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.9.28M
Float2.37M
Insiders74.50%
Institutions0.00%
Technical
SMA 501.255 (-17.0%)
SMA 2001.506 (-30.8%)
Beta—
S&P 52W Chg12.00%
Avg Vol (30d)2.08K
Avg Vol (10d)3.09K
Technical Indicators
RSI (14)44.0
MACD-0.3410
MACD Signal-0.3477
MACD Hist.+0.0066
BB Upper1.245 USD
BB Middle1.113 USD
BB Lower0.9802 USD
BB Width23.81%
ATR (14)0.1045 USD
Vol Ratio (20d)0.56x

About ViroGates (CPH: VIRO)

›

ViroGates (CPH: VIRO) is listed on Nasdaq Copenhagen, where its shares trade in DKK. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 7 employees.

The shares were at 7.100 DKK on 19 November 2026, down 44.3% over 52 weeks. Its 52-week range is 6.050 DKK to 17.40 DKK: the price is 59.2% below the high and 17.4% above the low.

Its market capitalisation is 65.90M DKK.

ViroGates reports return on equity of -53.6%, an operating margin of -104.7% and revenue down 33.6% year over year.

It holds more cash than debt, a net cash position of 11.25M DKK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.